Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
The base medium for this cell line is Dulbecco’s Modified Eagle’s Medium (ATCC® 30-2002™). To make the complete growth medium, add the following components to 500 ml of the base medium:
Fetal bovine serum (FBS; ATCC® 30-2020™) to a final concentration of 10%
25 µg/mL bovine pituitary extract (BPE)
5 µg/mL human recombinant insulin
6 ng/mL human recombinant epidermal growth factor (EGF)
Note: Do not filter complete medium
Subculture when culture reaches ~70-85% confluence.
A subcultivation ratio of 1:20 to 1:50 is recommended.Jiao J, et al. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res. 67: 6083-6091, 2007. PubMed:17616663
Wang S, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4(3): 209-221, 2003. PubMed: 14522255
Roy-Burman P, et al. Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr. Relat. Cancer 11: 225–254, 2004. PubMed: 15163300
Freeman D, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3(2): 117-130, 2003. PubMed: 12620407
